Sign in

CIK 0001752828 · <br>Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831702591
Phone
(908) 768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
  1. 424B3 Offering Prospectus
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. S-1/A Offering Registration Statement
  5. 424B3 Offering Prospectus
  6. 8-K Event Other events
  7. 424B3 Offering Prospectus
  8. S-1 Offering Registration Statement
  9. 4 Grant or award See Remarks acquired 65,617 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 131,234 shares (grant or award)
  11. 4 Grant or award See Remarks acquired 16,405 shares (grant or award)
  12. 4 Grant or award Pres, Functional Regeneration acquired 32,809 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 41,011 shares (grant or award)
  14. 4 Grant or award Chief Technology Officer acquired 19,686 shares (grant or award)
  15. 4 Grant or award Chief Business Officer acquired 16,405 shares (grant or award)
  16. EFFECT Other Notice of Effectiveness
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. 424B3 Offering Prospectus

Page 18 of 29 · 563 filings